# Targeted proteomics and quantification limits

Source: https://onco.cc/terms/targeted-proteomics-quantification/  
OnCo record `targeted-proteomics-quantification` (Term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A targeted protein assay measures selected peptide signals through a defined workflow. Reliable amounts require evidence about the quantitative range and precision of the assay.

## Summary

A primary multilaboratory study evaluated isotope-dilution multiple-reaction-monitoring assays for selected plasma proteins, examining recovery, reproducibility, linear range, detection and quantification limits. The performance belonged to the tested materials, analytes and protocols. It was not a universal certificate for all proteins or specimens. A reported protein amount should retain its measured peptide, calibration approach, sample preparation and supported range. An NIH workshop report on targeted mass spectrometry found no consensus on the criteria for a successful peptide assay and set out three tiers of assay performance, with response and calibration curves generated for each analyte in the relevant matrix to establish limits of detection and quantification; quantification rests on precursor-product ion pairs, called transitions, shown to be free of interference, and a surrogate protein standard must be shown to behave like the native analyte in tests of recovery after adding a known amount (Carr and colleagues, 2014). Stable-isotope-labelled internal standard peptides with the sequence of the analyte are spiked into the digest, and extended peptides or recombinant proteins can compensate for variability in digestion (Hoofnagle and colleagues, 2016). A multilaboratory plasma study reported reproducibility, recovery, linear range and limits of detection and quantification at microgram-per-millilitre protein concentrations (Addona and colleagues, 2009).

## Fields

- Kind: Term
- Last checked: 2026-11-10
- Also known as: targeted protein quantification; multiple-reaction-monitoring protein assays

## Notes

- Reading guide (OnCo inference built on the ICH definitions). A signal detected below the quantification limit is meaningful as detection, but it does not support a reliable amount, and neither it nor non-detection means biological zero. An upper limit also bounds the range, and a saturated response cannot separate larger inputs. Keep the denominator with every amount (for example femtomoles per microgram of total extracted protein or a concentration per volume), because it describes the mixture and not receptors per malignant cell; a selected peptide is a proxy for its source protein and cannot count intact receptors or surface copies. Tight repeats show precision, which can coexist with systematic bias. A standard added after digestion can control later measurement but cannot correct material already lost.
- Fictional worked example. A summary says 'receptor peptide R is absent' for an assay that detected R below its quantification limit. The result should read 'detected below the validated quantification limit', with the limit and units: it supports detection under that assay's rules but neither a dependable amount nor biological absence.
- Figure reading (fictional calibration, light and dark renders agree, no cutoff): a calibration plot has four regions in order of rising input, blank or background (no detection claim), detected below the lower limit of quantification (no reliable amount), validated range (report amount and units) and upper saturation (the response flattens), with replicate points scattered on the curve; a second panel says peptide amount is not surface location, and tight repeats alone do not rule out bias. Limits belong to the analyte and matrix.
- Assay card in words (a reading guide). Measures and how: selected peptide amounts, by extracting, digesting, measuring specified ions and fragments with controls, calibrating and assessing analyte performance. Input and tissue cost: a validated tissue, cell or fluid matrix; extraction and digestion consume material, and required mass or volume and fixation compatibility are assay-specific. Output and units: peptide identity, amount or ratio, with the denominator and the peptide-to-protein inference kept. Thresholds: analyte-specific limit of detection, quantification limit, upper limit, bias and precision acceptance and reportable range, with no universal limit or treatment threshold. Failure modes: incomplete recovery or digestion, shared peptides, interference, unstable standards, matrix effects and signal outside the validated range. Limits: no automatic intact-form, location, cell-of-origin, accessibility, occupancy or drug-dependence conclusion. Validation tier: fit-for-purpose research tiers describe analytical characterisation and do not themselves confer clinical approval.

## Sources

- Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma.: https://doi.org/10.1038/nbt.1546
- Carr et al., Targeted peptide measurements in biology and medicine (Molecular and Cellular Proteomics 2014): https://doi.org/10.1074/mcp.M113.036095
- Hoofnagle et al., Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based Assays (Clinical Chemistry 2016): https://doi.org/10.1373/clinchem.2015.250563

## Connected records

- technologies: [Proteomics & phosphoproteomics](https://onco.cc/technologies/proteomics/)
- terms: [Analytical versus clinical validation](https://onco.cc/terms/analytical-vs-clinical-validation/), [Immune measurements and product evidence](https://onco.cc/terms/immune-product-evidence/), [Reverse-phase protein array (RPPA)](https://onco.cc/terms/rppa/), [Tissue preparation and assay suitability](https://onco.cc/terms/tissue-preparation-assay-fit/)

---
JSON: https://onco.cc/api/v1/entities/targeted-proteomics-quantification.json